These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 24998740)

  • 1. Models matter: the search for an effective Staphylococcus aureus vaccine.
    Salgado-Pabón W; Schlievert PM
    Nat Rev Microbiol; 2014 Aug; 12(8):585-91. PubMed ID: 24998740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Staphylococcus aureus pathways to disease for vaccine development.
    DeDent A; Kim HK; Missiakas D; Schneewind O
    Semin Immunopathol; 2012 Mar; 34(2):317-33. PubMed ID: 22130613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus antigens and challenges in vaccine development.
    Middleton JR
    Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: is an additional vaccine needed or possible?
    Shinefield HR
    Vaccine; 2006 Apr; 24 Suppl 2():S2-65-9. PubMed ID: 16823932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage.
    Botelho-Nevers E; Verhoeven P; Paul S; Grattard F; Pozzetto B; Berthelot P; Lucht F
    Expert Rev Vaccines; 2013 Nov; 12(11):1249-59. PubMed ID: 24111513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a future for a Staphylococcus aureus vaccine?
    Proctor RA
    Vaccine; 2012 Apr; 30(19):2921-7. PubMed ID: 22115633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prospects for developing a vaccine against Staphylococcus aureus.
    Lee JC
    Trends Microbiol; 1996 Apr; 4(4):162-6. PubMed ID: 8728611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges for a universal Staphylococcus aureus vaccine.
    Proctor RA
    Clin Infect Dis; 2012 Apr; 54(8):1179-86. PubMed ID: 22354924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice.
    Yi SQ; Zhang XY; Yang YL; Yang Y; Liu SL; Fu L; Yu CM; Chen W
    Microbiol Immunol; 2012 Jun; 56(6):406-10. PubMed ID: 22420921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel targeted immunotherapy approaches for staphylococcal infection.
    Otto M
    Expert Opin Biol Ther; 2010 Jul; 10(7):1049-59. PubMed ID: 20528609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
    Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD
    Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination and passive immunisation against Staphylococcus aureus.
    Schaffer AC; Lee JC
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.
    Schaffer AC; Solinga RM; Cocchiaro J; Portoles M; Kiser KB; Risley A; Randall SM; Valtulina V; Speziale P; Walsh E; Foster T; Lee JC
    Infect Immun; 2006 Apr; 74(4):2145-53. PubMed ID: 16552044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli.
    Wacker M; Wang L; Kowarik M; Dowd M; Lipowsky G; Faridmoayer A; Shields K; Park S; Alaimo C; Kelley KA; Braun M; Quebatte J; Gambillara V; Carranza P; Steffen M; Lee JC
    J Infect Dis; 2014 May; 209(10):1551-61. PubMed ID: 24308931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward a Staphylococcus aureus vaccine.
    Daum RS; Spellberg B
    Clin Infect Dis; 2012 Feb; 54(4):560-7. PubMed ID: 22186773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection.
    Rauch S; Gough P; Kim HK; Schneewind O; Missiakas D
    Infect Immun; 2014 Nov; 82(11):4889-98. PubMed ID: 25183728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection.
    Anderson AS; Scully IL; Buurman ET; Eiden J; Jansen KU
    mBio; 2016 Mar; 7(2):e00225. PubMed ID: 26956591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with a UV-irradiated genetically attenuated mutant of Staphylococcus aureus provides protection against subsequent systemic infection.
    Burnside K; Lembo A; Harrell MI; Klein JA; Lopez-Guisa J; Siegesmund AM; Torgerson TR; Oukka M; Molina DM; Rajagopal L
    J Infect Dis; 2012 Dec; 206(11):1734-44. PubMed ID: 22966130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapeutic approaches against Staphylococcus aureus.
    Verkaik NJ; van Wamel WJ; van Belkum A
    Immunotherapy; 2011 Sep; 3(9):1063-73. PubMed ID: 21913829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.